Drug Designing: Open Access : Citations & Metrics Report
Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.
Following are the list of articles that have cited the articles published in Drug Designing: Open Access.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 32 | 30 | 31 | 67 | 2 | 5 | 16 | 18 | 12 | 14 | 24 | 6 |
Research, Review articles and Editorials |
0 | 2 | 2 | 24 | 33 | 0 | 4 | 15 | 15 | 12 | 10 | 25 | 6 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
14 | 30 | 27 | 7 | 35 | 2 | 1 | 1 | 3 | 0 | 4 | 3 | 0 |
Conference proceedings |
0 | 5 | 5 | 0 | 0 | 0 | 124 | 81 | 41 | 56 | 0 | 0 | 58 |
Citations received as per Google Scholar, other indexing platforms and portals |
45 | 51 | 54 | 62 | 43 | 41 | 41 | 23 | 48 | 16 | 10 | 5 | 0 |
| Journal total citations count | 456 |
| Journal impact factor | 1.70 |
| Journal 5 years impact factor | 1.5 |
| Journal cite score | 1.57 |
| Journal h-index | 9 |
| Journal h-index since 2019 | 7 |
Important citations (297)
A first-in-human, phase 1, dose-escalation study of abbv-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors. |
|
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study |
|
Commentary to article entitled: chemo proteomics, a valuable tool for biomarker and drug discovery |
|
Recent advances in in-vitro assays for type 2 diabetes mellitus: an overview. |
|
Role of edible mushroom as a potent therapeutics for the diabetes and obesity |
|
Statistical applications for biosimilar product development |
|
Glycosylation of therapeutic proteins: a critical quality attribute |
|
A further look at the current equivalence test for analytical similarity assessment |
|
Analytical comparability and similarity |
|
An evaluation roadmap for critical quality attributes from tier 1 in analytical similarity assessment |
|
Microbial technologies for biotherapeutics production: key tools for advanced biopharmaceutical process development and control |
|
Advancements in novel drug delivery systems and opportunities for indian pharmaceutical companies |
|
Application of nanotechnology to the extraction of herbal components for medicinal uses |
|
Sciences an overview of breast cancer treatment |
|
Efficient pharmaceutical formulation designs and their development using mathematical and statistical analysis |
|
Statistical designs for pharmaceutical/clinical development |
|
From idea to market: the drug design, development & approval process |
|
Fast dissolving drug delivery system: a review 2015 |
|
Nano-medicine: promising drug for future |
|
From idea to market: the drug design, development & approval process |
|